Download PDF
Dtsch Med Wochenschr 2008; 133(48): 2516-2521
DOI: 10.1055/s-0028-1100950
Übersicht | Review article
Intensivmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Infarktbedingter kardiogener Schock: Revaskularisation, mechanische Unterstützung und medikamentöse Therapie

Cardiogenic shock in myocardial infarction: revascularization, mechanical support and pharmacotherapyM. Buerke1 , M. Ruß1 , K. Werdan1
  • 1Institut Universitätsklinik und Poliklinik für Innere Medizin III, Klinikum der Martin-Luther-Universität Halle
Further Information

Publication History

eingereicht: 28.7.2008

akzeptiert: 17.11.2008

Publication Date:
19 November 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

kardiogener Schock - medikamentöse Therapie - Revaskularisation - mechanische Unterstützung

Keywords

cardiogenic shock - pharmacotherapy - revascularization - mechanical support

Literatur

  • 1 Anderson R D, Ohman E M, Holme Jr D R, Col J, Stebbins A L, Bates E R. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study.  J Amer Coll Cardiol. 1997;  30 708-715
    Google Scholar
  • 2 Babaev A, Frederick P D, Pasta D J, Every N, Sichrovsky T, Hochman J S. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.  JAMA. 2005;  294 448-454
    Google Scholar
  • 3 Brookes C, Ravn H, White P, Moeldrup U, Oldershaw P, Redington A. Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance.  Circulation. 1999;  100 761-767
    Google Scholar
  • 4 Burkhoff D, Cohen H, Brunckhorst C, O’Neill W W. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.  Am Heart J. 2006;  152 469 e1-e8
    Google Scholar
  • 5 Cassidy S S, Mitchell J H. Effects of positive pressure breathing on right and left ventricular preload and afterload.  Fed Proc. 1981;  40 2178-2181
    Google Scholar
  • 6 Chen E W, Canto J G, Parsons L S. et al . Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.  Circulation. 2003;  108 951-957
    Google Scholar
  • 7 Christoph A, Prondzinsky R, Russ M, Janusch M, Schlitt A, Lemm H, Reith S, Werdan K, Buerke M. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.  Acute Cardiol Care. 2008;  10 49-57
    Google Scholar
  • 8 Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, Krakover R, Golick A, Vered Z. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock.  Eur Heart J. 2003;  24 1287-1295
    Google Scholar
  • 9 Cotter G, Williams S G, Vered Z, Tan L B. Role of cardiac power in heart failure.  Curr Opin Cardiol. 2003;  18 215-222
    Google Scholar
  • 10 Cuffe M S, Califf R M, Adams K F Jr. et al . Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.  JAMA. 2002;  287 1541-1547
    Google Scholar
  • 11 Delle Karth G, Buberl A, Geppert A. et al . Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.  Acta Anaesthesiol Scand. 2003;  47 1251-1256
    Google Scholar
  • 12 Fincke R, Hochman J S, Lowe A M, Menon V, Slater J N, Webb J G, LeJemtel T H, Cotter G. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.  J Am Coll Cardiol. 2004;  44 340-348
    Google Scholar
  • 13 Friedrich J O, Adhikari N, Herridge M S, Beyene J. Low-dose dopamine increases urine output but does not prevent renal dysfunction or death.  Ann Intern Med. 2005;  142 510-524
    Google Scholar
  • 14 Granger C B, Mahaffey K W, Weaver W D. et al . Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.  Circulation. 2003;  108 1184-1190
    Google Scholar
  • 15 Hochman J S, Sleeper L A, Webb J G, Dzavik V, Buller C E, Aylward P, Col J, White H D. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.  JAMA. 2006;  295 2511-2515
    Google Scholar
  • 16 Hochman J S, Sleeper L A, Webb J G. et al . Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.  N Engl J Med. 1999;  341 625-634
    Google Scholar
  • 17 Hochman J S, Boland J, Sleeper L A. et al . Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of an International Registry.  Circulation. 1995;  91 873-881
    Google Scholar
  • 18 Jacobs A K, Leopold J A, Bates E. et al . Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry.  J Am Coll Cardiol. 2003;  41 1273-n
    Google Scholar
  • 19 Jolly S, Newton G, Horlick E. et al . Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.  Amer J Cardiol. 2005;  96 1617-1620
    Google Scholar
  • 20 Klein L W, Shaw R E, Krone R J. et al . Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.  Am J Cardiol. 2005;  96 35-41
    Google Scholar
  • 21 Koreny M, Geppert A, Wutte M, Karth G D, Heinz G, Siostrzonek P. Effects of milrinone on pulmonary gas exchange in catecholamine-dependent heart failure.  Amer J Cardiol. 2000;  86 570-573
    Google Scholar
  • 22 Montalescot G, Barragan P, Wittenberg O. et al, for the ADMIRAL Investigators . Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.  N Engl J Med. 2001;  344 1895-1903
    Google Scholar
  • 23 Ohman E M, Nanas J, Stomel R J. et al . Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.  J Thromb Thrombolysis. 2005;  19 33-39
    Google Scholar
  • 24 Picard M H, Davidoff R, Sleeper L A, Mendes L A, Thompson C R, Dzavik V, Steingart R, Gin K, White H D, Hochman J S. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.  Circulation. 2003;  107 279-284
    Google Scholar
  • 25 Ramanathan K. Harkness S M. Nayar A C. Cosmi J E. Sleeper L S. White H D. Davidoff R. Hochman J S. Cardiogenic shock in patients with preserved left ventricular systolic function: characteristics and insight into mechanisms.  Circulation. 2004;  43 241A
    Google Scholar
  • 26 Russ M A, Prondzinsky R, Christoph A. et al . Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.  Crit Care Med. 2007;  35 2732-2739
    Google Scholar
  • 27 Sanborn T A, Sleeper L A, Webb J G. et al . Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.  J Am Coll Cardiol. 2003;  42 1373-1379
    Google Scholar
  • 28 Steg P G, Bonnefoy E, Chabaud S, Lapostolle F, Dubien P Y, Cristofini P, Leizorovicz A, Touboul P. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.  Circulation. 2003;  108 2851-2856
    Google Scholar
  • 29 Tayara W, Starling R C, Yamani M H, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment.  J Heart Lung Transplant. 2006;  25 504-509
    Google Scholar
  • 30 Theroux P, Armstrong P W, Mahaffey K W. et al . Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.  Eur Heart J. 2005;  26 1964-1970
    Google Scholar
  • 31 Thiele H, Sick P, Boudriot E, Diederich K W, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.  Eur Heart J. 2005;  26 1276-1283
    Google Scholar
  • 32 Urban P M, Freedman R J, Ohman E M, Stone G W, Christenson J T, Cohen M, Miller M F, Joseph D L, Bynum D Z, Ferguson III J J. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation.  Am J Cardiol. 2004;  94 181-185
    Google Scholar
  • 33 Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini G F. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.  Int J Cardiol. 2007;  114 176-182
    Google Scholar
  • 34 Yehudai L, Reynolds H R, Schwarz S A, Harkness S M, Picard M H, Davidoff R, Hochman J S. Serial echocardiograms in patients with cardiogenic shock: analysis of the SHOCK Trial.  J Am Coll Cardiol. 2006;  47 (suppl A) 111A
    Google Scholar
  • 35 Zeymer U, Vogt A, Zahn R, Weber M A, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus K L. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK).  Eur Heart J. 2004;  25 322-328
    Google Scholar
  • 36 Zion M M, Balkin J, Rosenmann D, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group.  Chest. 1990;  98 1331-5
    Google Scholar

Prof. Dr. med. M. Buerke

Universitätsklinik und Poliklinik für Innere Medizin III, Klinikum der Martin-Luther-Universität

Ernst-Grube Str. 40

06097 Halle/Saale

Phone: 0345/557 2847

Fax: 0345/557 2801

Email: michael.buerke@medizin.uni-halle.de

      >